Investing Haven
No Result
View All Result
Gold Silver Investing >>
CRYPTO INVESTING >>
  • 2025 Forecasts
    • 10 market predictions
    • Dow Jones forecast
    • S&P 500 forecast 2025
    • Nasdaq prediction 2025
    • Best altcoins to buy
    • Best crypto to buy now
    • Which crypto will explode
    • 15 crypto forecasts 2025
    • Which precious metal to buy
  • Silver
    • Silver prediction 2025 – 2030
    • Will silver exceed $30?
    • When will silver hit $50?
    • Can silver hit $100?
    • Silver shortage
    • 50-year silver chart
    • Silver bullish reversal
    • Silver seasonality charts
    • How to invest in silver
  • Gold
    • Gold prediction 2025 – 2030
    • Will gold set new ATH?
    • Will gold hit $3,000?
    • Can gold hit $10,000?
    • Gold chart 10 years
    • Gold chart 50 years
    • Gold chart 100 years
    • Gold silver ratio
    • Gold seasonality charts
  • Commodities
    • Coffee forecasts
    • Sugar forecasts
    • Nickel forecasts
    • Lithium investing
  • Crypto forecasts
    • BTC prediction 2025 – 2030
    • ETH prediction 2025 – 2030
    • SOL prediction 2025 – 2030
    • XRP prediction 2025 – 2030
    • XLM prediction 2025 – 2030
    • BNB prediction 2025 – 2030
    • ADA prediction 2025 – 2030
    • AVAX prediction 2025 – 2030
    • KAS prediction 2025 – 2030
    • NEAR prediction 2025 – 2030
    • BCH prediction 2025 – 2030
    • LINK prediction 2025 – 2030
    • DOT prediction 2025 – 2030
    • SUI prediction 2025 – 2030
    • ICP prediction 2025 – 2030
    • LTC prediction 2025 – 2026
    • STX prediction 2025 – 2030
    • DOGE prediction 2025 – 2030
    • SHIB prediction 2025 – 2030
    • PEPE prediction 2025 – 2030
    • FLOKI prediction 2025 – 2030
    • WIF prediction 2025 – 2030
    • ONDO prediction 2025 – 2030
  • News
    • Crypto news
    • Commodities
    • Markets & Stocks
  • Login
Investing Haven
No Result
View All Result

Home » Trendwatching » 4 Pharmaceutical Stocks Making a Comeback in 2018

4 Pharmaceutical Stocks Making a Comeback in 2018

Ralf Lai by Ralf Lai
September 8, 2024
in Trendwatching
Pharma stocks

Pills and capsules in medical vial

2k
VIEWS
Share on FacebookShare on Twitter

Approximately 2 weeks ago, we wrote about 4 biotechnology stocks that are worth considering in 2018. Biotech falls in the broad healthcare sector. However, this article is about pharmaceutical stocks. We selected 4 great pharma stocks to consider in 2018!

We briefly explained the difference between biotechnology companies and the pharmaceutical companies. We would like to elaborate a little further here. The traditional drug manufacturers (also known as pharmaceutical companies) use simple chemical as raw materials, react together under certain conditions and, eventually, formulate the finished product into mainly tablet form if not in capsules. There is always an exception that some pharmaceutical companies do manufacture vaccines in solution form that makes them pseudo-biopharmaceutical. Paracetamol (Panadol) and antibiotics are easy examples of drugs that are produced by general pharmaceutical companies that have to be orally consumed.  On the other hand, biotechnology companies produce biologics that is manufactured from living systems such as enzyme or microorganisms which has to be administered intravenously. This biologic is generally packed into ampoules or sealed bottles. More detail information can be referred from here.

Pharmaceutical stocks are bound to make a great comeback based on the data collected the previous year. More and more people are getting concerned about their health and this has drastically escalated the sales of the medicinal drugs across the globe. Stocks of companies like the Absolute Pharmacy are increasing drastically as the sale of medicine is proportional to the excellent service they are providing their client for their various health issues. You could click here to more about Absolute Pharmacy and find out how they have managed to stay on top with the services they are providing.

Though there are 7 major pharmaceutical ETFs, we will use XPH – SPDR S&P Pharmaceuticals ETF as a representation. This ETF is one of several options for investors looking for exposure to the U.S. pharmaceutical industry, a sub-sector of the health care. It can post big returns during periods of consolidation or as a result of advancements in medicine. InvestingHaven uses it as a way to gauge whether there is significant move to the upside or downside.

pharma stocks 2018 XPH

Weekly chart of XPH

The monthly chart of XPH has been consolidating sideway since Feb 2016. There is a possibility that it could mimic other sectors, and end up in a cup shape in the near future. The price action after week of 22 Jan are just a bullish projection. This projection will be invalidated once price breaks down hard below the potential cup support.

Pharma stock #1: Eli Lilly and Company (NYSE ticker – LLY)

Eli Lilly and Company is a global pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Col. Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War, after whom the company was named. Lilly’s notable achievements include being the first company to mass-produce penicillin, the polio vaccine developed by Jonas Salk, and insulin. Lilly is currently the largest manufacturer of psychiatric medications and produces Prozac (fluoxetine), Dolophine (methadone), Cymbalta (duloxetine), and Zyprexa (olanzapine).

pharma stocks 2018 Lilly

Monthly chart of Eli Lilly & Co

The cup shaped bottoming price action is almost completed in the monthly chart of LLY. Last traded price is 87.08. For the bullish care, it should not have problem reaching ~97.5 in 2018 although less than expected earning can pull the price down. Immediate downside support lies at ~82.3 and failure to support could see price going back to ~77.

Pharma stock #2: Bristol-Myers Squibb (NYSE ticker – BMY)

Bristol-Myers Squibb is a global biopharmaceutical company that develops and delivers innovative medicines that help patients prevail over serious diseases. It is a diversified company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. Hence, the company manufactures both oral tablets as well as biologic products that see to cure or alleviate illness such as cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders

pharma stocks 2018 bristol myers

Monthly chart of Bristol Myers Squibb

The stock price of BMY had a huge cup consolidation pattern that dates back to 2000. At the time of writing, price trades at 64.25. Our upside target project will be ~76.8, if this multi-year resistance is breached, we expect the price to continue going up steadily. What happens if price breaks down? Immediate support lies around 59 followed by 51 if the former fails to support.

Pharma stock #3: Merck & Co., Inc (NYSE ticker – MRK)

Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company has operations in pharmaceutical, animal health, and consumer care. The most aggressive endeavour by Merck was the acquisition of Schering-Plough in 2009.

pharma stocks 2018 MRK

Monthly chart of Merck

It is not hard to see the elongated W embedded inside the cup pattern of MRK in its monthly chart. Immediate upside task is to clear 67 and at least getting to ~76.4 in 2018 before launching a breakout attempt at previous resistance of ~97 most probably by 2019. The first downside support is quite a distance away at ~54. Though we are bias to upside, price of MRK could consolidate for another few weeks before breaking 67.

Pharma stock #4: Pfizer Inc (NYSE ticker – PFE)

Pfizer Inc, the world’s largest research-based pharmaceutical company, discovers, develops, manufactures and markets prescription medicines in 11 therapeutic areas including oncology, cardiovascular, pain, neuroscience and infectious diseases, including HIV/AIDS. Pfizer is also the world’s largest animal health company. The most famous drug produced by Pfizer will be non-other-than the little rhombic blue pill – VIAGRA that use to help patients with erectile dysfunction problem. Many competitors are already allowed to manufacture their own version of VIAGRA when Pfizer’s exclusive market right expires in 2020.

pharma stocks 2018 PFE

Monthly chart of Pfizer

We believe our readers are able to tell us where the potential price target is for 2018. Yes, a challenge towards 48 – 50 is highly possible in 2018. On the flipside, the immediate support sits at ~36 after which 32 will be important should price reverse.

Generally the pharmaceutical companies are giving decent dividend with stable price movement but the growth could be very slower compare to biotech companies. There is also an emerging trend that these companies shifting towards biopharma to get into the biotech market because many of their generic drugs’ patents will expire one after another soon.

One of the most efficient ways companies are increasing their sales is by changing the pharmaceutical product wrappers using advance cost cutting machines which offers a better quality of packaging. This is proving to be beneficial to both the consumers and the company as the consumers get good quality packed medicines and the company builds good goodwill with the customers.

Be sure to consult financial adviser and healthcare expert for advice should you consider at least one pharmaceutical company in your portfolio.

10-YEAR ANNIVERSARY OFFER: InvestingHaven.com celebrates 10 years. Temporarily, you can enjoy a discount on our premium gold/silver and crypto reports. Or you can become a VIP member. Go to our anniversary deals >>
Receive our weekly newsletter.

premium service SP-500 premium service trade alerts premium service crypto teaser 

No related posts.

Tags: BMYLLYMRKPFEXPH
Ralf Lai

Ralf Lai

Ralf Lai has a scientific background. He learnt investing the hard way. He invested his hard-earned savings in stocks back in 2011, at the highs, partly due to his ignorant beliefs in financial news.He decided to stop following mainstream financial news, and start reading every technical analysis book available. In doing his analysis he discovered a passion in researching the WHY question behind movements. Combined with the fact that he is a very curious person, and an insatiable appetite to learn, he started learning the ability to decipher charts.He has developed into a TOP-DOWN approach, meaning monthly historical data and daily or 4 hour entry using candle as an entry signal, indicator. With his sharp analysis he joined the InvestingHaven team in October 2017.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Connect with InvestingHaven

Receive top notch forecasts for free.

*We hate spam as you do.

Site Navigation

  • RSS Feed
  • About us
  • Advertising
  • Sponsored Content Policy
  • Mission 2026
  • Sitemap
  • Privacy & Disclaimer
  • Terms of Service
  • Contact Us
investing haven logo

Precious metals market analysis including gold and silver price predictions. Crypto market analysis including highly accurate BTC ETH SOL XRP forecasts.

Copyright © 2025 InvestingHaven

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Receive top notch forecasts for free.

*We hate spam as you do.

No Result
View All Result
  • News
  • 2025 Forecasts
    • 10 market predictions
    • Dow Jones forecast 2025
    • S&P 500 forecast 2025
    • Nasdaq prediction 2025
    • Best crypto to buy now
    • Which crypto will explode
    • Best altcoins to buy
    • 15 crypto forecasts 2025
    • Which precious metal to buy
  • Silver articles
    • Silver prediction 2025 – 2030
    • Will silver exceed $30?
    • When will silver hit $50?
    • Can silver hit $100?
    • Silver shortage
    • 50-year silver chart
    • Silver bullish reversal
    • Silver seasonality charts
    • How to invest in silver
  • Gold
    • Gold prediction 2025 – 2030
    • Will gold set new ATH?
    • Will gold hit $3,000?
    • Can gold hit $10,000?
    • Gold chart 10 years
    • Gold chart 50 years
    • Gold chart 100 years
    • Gold silver ratio
    • Gold seasonality charts
  • Commodities
    • Sugar forecasts
    • Coffee forecasts
    • Nickel forecasts
    • Lithium investing
  • Crypto news
  • Crypto forecasts
    • BTC prediction 2025 – 2030
    • ETH prediction 2025 – 2030
    • SOL prediction 2025 – 2030
    • XRP prediction 2025 – 2030
    • XLM prediction 2025 – 2030
    • BNB prediction 2025 – 2030
    • ADA prediction 2025 – 2030
    • AVAX prediction 2025 – 2030
    • KAS prediction 2025 – 2030
    • NEAR prediction 2025 – 2030
    • BCH prediction 2025 – 2030
    • LINK prediction 2025 – 2030
    • DOT prediction 2025 – 2030
    • SUI prediction 2025 – 2030
    • ICP prediction 2025 – 2030
    • LTC prediction 2025 – 2026
    • STX prediction 2025 – 2030
    • DOGE prediction 2025 – 2030
    • SHIB prediction 2025 – 2030
    • PEPE prediction 2025 – 2030
    • FLOKI prediction 2025 – 2030
    • WIF prediction 2025 – 2030
    • ONDO prediction 2025 – 2030
  • Premium Crypto Alerts
  • Premium services

Copyright © 2025 InvestingHaven